Latest Updates

Revenues has been posted at Rs 9,461 million, showing a growth of 33 per cent Y-o-Y

Announces US launch of authorised generics for Benicar, Benicar HCT, Azor and Tribenzor

To enable drug development and chronic disease management with Watson

To market and distribute a diverse portfolio of eight injectable ANDAs

Pharma exports, which is currently pegged at $16.9 billion, is expected to grow at 10 per cent during the current year…

In Q2 FY17, EBITDA is at Rs 6.4 billion and profit after tax at Rs 2.9 billion

Campus competitions, poster entries were held during the seminar

Along with a $20 million investment directly into the business, the deal includes acquiring stakes from Kotak Private Equity and a…

The Mumbai-based drug major has recently signed an agreement with ICMR and Madhya Pradesh government to work towards eradicating…

The court ruled that the government can fix the retail price of a formulation without first fixing the sale price of a bulk drug…